MeiraGTx Holdings (MGTX) Non-Current Deferred Tax Liability (2019 - 2023)
MeiraGTx Holdings (MGTX) posted Non-Current Deferred Tax Liability of $184000.0 for Q3 2023, down 2.65% on a QoQ basis from $189000.0 in Q2 2023, and up 7.6% year-over-year from $171000.0 in Q3 2022.
MeiraGTx Holdings (MGTX) Non-Current Deferred Tax Liability (2019 - 2023) Analysis & Trends
MeiraGTx Holdings' Non-Current Deferred Tax Liability history runs 5 years deep, the most recent figure standing at $184000.0 for Q3 2023.
- Quarterly Non-Current Deferred Tax Liability rose 7.6% year-over-year to $184000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $184000.0 (up 7.6% YoY) and the FY2022 annual result came in at $186000.0, down 5.1% from the prior year.
- Non-Current Deferred Tax Liability was $184000.0 for Q3 2023 at MeiraGTx Holdings, down from $189000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $214000.0 in Q4 2020 and bottomed at $171000.0 in Q3 2022.
- A 5-year average of $193676.5 and a median of $194159.0 in 2020 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2020 — Non-Current Deferred Tax Liability advanced 9.71% — and 2022, when it slipped 14.93%.
- MeiraGTx Holdings' Non-Current Deferred Tax Liability stood at $195053.0 in 2019, then advanced by 9.71% to $214000.0 in 2020, then decreased by 8.41% to $196000.0 in 2021, then decreased by 5.1% to $186000.0 in 2022, then fell by 1.08% to $184000.0 in 2023.
- Business Quant data shows MGTX's Non-Current Deferred Tax Liability at $184000.0 in Q3 2023, $189000.0 in Q2 2023, and $189000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 184,000.00 |
| Sep 30, 2023 | 184,000.00 |
| Jun 30, 2023 | 189,000.00 |
| Jun 30, 2023 | 189,000.00 |
| Mar 31, 2023 | 189,000.00 |
| Mar 31, 2023 | 189,000.00 |
| Dec 31, 2022 | 186,000.00 |
| Dec 31, 2022 | 186,000.00 |
| Sep 30, 2022 | 171,000.00 |
| Sep 30, 2022 | 171,000.00 |
| Jun 30, 2022 | 181,000.00 |
| Jun 30, 2022 | 181,000.00 |
| Mar 31, 2022 | 194,000.00 |
| Mar 31, 2022 | 194,000.00 |
| Dec 31, 2021 | 196,000.00 |
| Dec 31, 2021 | 196,000.00 |
| Sep 30, 2021 | 201,000.00 |
| Sep 30, 2021 | 201,000.00 |
| Jun 30, 2021 | 206,000.00 |
| Jun 30, 2021 | 206,000.00 |